Primary effusion lymphoma

Common Name(s)

Primary effusion lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Primary effusion lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Primary effusion lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Primary effusion lymphoma" returned 147 free, full-text research articles on human participants. First 3 results:

Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma presenting with cardiac tamponade: A case report.
 

Author(s): Hee-Jun Kim, Kyoungyul Lee, Chang-Hwan Yoon, Soo-Mee Bang

Journal: Medicine (Baltimore). 2017 Oct;96(43):e8010.

 

Primary effusion lymphoma (PEL) is a rare disease of lymphomatous effusion in the body cavities in the absence of detectable mass and lymphadenopathy. PEL is predominantly related to the immunosuppressed patients infected with human herpes virus 8 (HHV-8). PEL-like lymphoma is negative ...

Last Updated: 31 Dec 1969

Go To URL
Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma.
 

Author(s): Prabha Shrestha, David A Davis, Ravindra P Veeranna, Robert F Carey, Coralie Viollet, Robert Yarchoan

Journal:

 

Primary effusion lymphoma (PEL) is an aggressive B-cell lymphoma with poor prognosis caused by Kaposi's sarcoma-associated herpesvirus (KSHV). Previous studies have revealed that HIF-1α, which mediates much of the cellular response to hypoxia, plays an important role in life cycle ...

Last Updated: 31 Dec 1969

Go To URL
Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
 

Author(s): L Dai, Z Lin, J Qiao, Y Chen, E K Flemington, Z Qin

Journal: Oncogene. 2017 Aug;36(35):5068-5074.

 

Primary effusion lymphoma (PEL) is a highly aggressive B-cell malignancy that is closely associated with one of oncogenic viruses infection, Kaposi's sarcoma-associated herpesvirus. PEL prognosis is poor and patients barely survive >6 months even following active chemotherapy interventions. ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Primary effusion lymphoma" returned 10 free, full-text review articles on human participants. First 3 results:

Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
 

Author(s): William R Foster, Alina Bischin, Russell Dorer, David M Aboulafia

Journal: Clin Lymphoma Myeloma Leuk. 2016 06;16(6):311-21.

 

Primary effusion lymphoma (PEL) is a rare non-Hodgkin lymphoma subtype primarily seen in human immunodeficiency virus (HIV)-infected individuals with low CD4(+) cell counts and elevated HIV viral loads. It has always been associated with human herpesvirus type 8 (HHV-8) and in 80% ...

Last Updated: 31 Dec 1969

Go To URL
Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of 54 cases in the literature.
 

Author(s): William Wu, Wonita Youm, Sherif A Rezk, Xiaohui Zhao

Journal: Am. J. Clin. Pathol.. 2013 Aug;140(2):258-73.

 

To report a patient with primary effusion lymphoma who was negative for human herpesvirus-8 (HHV-8), human immunodeficiency virus, Epstein-Barr virus, hepatitis C virus, and hepatitis B virus, as well as review 54 reported cases of HHV-8-unrelated primary effusion lymphoma (PEL)-like ...

Last Updated: 31 Dec 1969

Go To URL
Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma.
 

Author(s): Tamara K Moyo, Kristy L Richards, Blossom Damania

Journal: Clin Adv Hematol Oncol. 2010 May;8(5):372-4.

 

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 26 May 2017

Go to URL

Last Updated: 18 Oct 2017

Go to URL
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
 

Status: Recruiting

Condition Summary: AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; CD20 Positive; HIV Positivity

 

Last Updated: 11 Dec 2017

Go to URL